Raúl A. Bowden

1.2k total citations
17 papers, 981 citations indexed

About

Raúl A. Bowden is a scholar working on Small Animals, Endocrinology and Immunology. According to data from OpenAlex, Raúl A. Bowden has authored 17 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Small Animals, 10 papers in Endocrinology and 6 papers in Immunology. Recurrent topics in Raúl A. Bowden's work include Brucella: diagnosis, epidemiology, treatment (15 papers), Escherichia coli research studies (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Raúl A. Bowden is often cited by papers focused on Brucella: diagnosis, epidemiology, treatment (15 papers), Escherichia coli research studies (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Raúl A. Bowden collaborates with scholars based in Argentina, France and United States. Raúl A. Bowden's co-authors include Silvia M. Estein, Juliana Cassataro, Guillermo H. Giambartolomei, Carlos A. Fossati, Carlos A. Velikovsky, Axel Cloeckaert, Silvia de la Barrera, Nieves Vizcaı́no, Laura Bruno and Karina A. Pasquevich and has published in prestigious journals such as Infection and Immunity, Vaccine and Electrophoresis.

In The Last Decade

Raúl A. Bowden

17 papers receiving 938 citations

Peers

Raúl A. Bowden
Laura Bruno Argentina
G Dubray France
G.G. Alton Australia
P Nicoletti United States
M Plommet France
Diogo M. Magnani United States
DL Watson Australia
Raúl A. Bowden
Citations per year, relative to Raúl A. Bowden Raúl A. Bowden (= 1×) peers Jean-Michel Verger

Countries citing papers authored by Raúl A. Bowden

Since Specialization
Citations

This map shows the geographic impact of Raúl A. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raúl A. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raúl A. Bowden more than expected).

Fields of papers citing papers by Raúl A. Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raúl A. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raúl A. Bowden. The network helps show where Raúl A. Bowden may publish in the future.

Co-authorship network of co-authors of Raúl A. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Raúl A. Bowden. A scholar is included among the top collaborators of Raúl A. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raúl A. Bowden. Raúl A. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cassataro, Juliana, Karina A. Pasquevich, Silvia M. Estein, et al.. (2007). A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination. Vaccine. 25(32). 5958–5967. 40 indexed citations
2.
Cassataro, Juliana, Karina A. Pasquevich, Silvia M. Estein, et al.. (2007). A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination. Vaccine. 25(22). 4437–4446. 66 indexed citations
3.
Cassataro, Juliana, Carlos A. Velikovsky, Laura Bruno, et al.. (2007). Improved Immunogenicity of a Vaccination Regimen Combining a DNA Vaccine Encoding Brucella melitensis Outer Membrane Protein 31 (Omp31) and Recombinant Omp31 Boosting. Clinical and Vaccine Immunology. 14(7). 869–874. 44 indexed citations
4.
Cassataro, Juliana, Silvia M. Estein, Karina A. Pasquevich, et al.. (2005). Vaccination with the RecombinantBrucellaOuter Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+T Helper 1 Response That Protects againstBrucella melitensisInfection. Infection and Immunity. 73(12). 8079–8088. 105 indexed citations
5.
Cassataro, Juliana, Carlos A. Velikovsky, Silvia de la Barrera, et al.. (2005). A DNA Vaccine Coding for theBrucellaOuter Membrane Protein 31 Confers Protection againstB. melitensisandB. ovisInfection by Eliciting a Specific Cytotoxic Response. Infection and Immunity. 73(10). 6537–6546. 100 indexed citations
6.
Estein, Silvia M., et al.. (2004). Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis. Veterinary Microbiology. 102(3-4). 203–213. 29 indexed citations
7.
Estein, Silvia M., Juliana Cassataro, Nieves Vizcaı́no, et al.. (2003). The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes and Infection. 5(2). 85–93. 51 indexed citations
8.
Giguère, Steeve, et al.. (2003). Endometrial IL-1β, IL-6 and TNF-α, mRNA expression in mares resistant or susceptible to post-breeding endometritis. Veterinary Immunology and Immunopathology. 96(1-2). 31–41. 82 indexed citations
9.
Velikovsky, Carlos A., Fernando A. Goldbaum, Juliana Cassataro, et al.. (2003). BrucellaLumazine Synthase Elicits a Mixed Th1-Th2 Immune Response and Reduces Infection in Mice Challenged withBrucella abortus544 Independently of the Adjuvant Formulation Used. Infection and Immunity. 71(10). 5750–5755. 84 indexed citations
10.
Cloeckaert, Axel, Nieves Vizcaı́no, Jean‐Yves Paquet, Raúl A. Bowden, & Philip H. Elzer. (2002). Major outer membrane proteins of Brucella spp.: past, present and future. Veterinary Microbiology. 90(1-4). 229–247. 150 indexed citations
11.
Cassataro, Juliana, Carlos A. Velikovsky, Guillermo H. Giambartolomei, et al.. (2002). Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine. 20(11-12). 1660–1669. 20 indexed citations
12.
Velikovsky, Carlos A., Juliana Cassataro, Guillermo H. Giambartolomei, et al.. (2002). A DNA Vaccine Encoding Lumazine Synthase fromBrucella abortusInduces Protective Immunity in BALB/c Mice. Infection and Immunity. 70(5). 2507–2511. 86 indexed citations
13.
Estein, Silvia M., Pablo C. Baldi, & Raúl A. Bowden. (2002). Comparison of Serological Tests Based on Outer Membrane or Internal Antigens for Detecting Antibodies to Brucella Ovis in Infected Flocks. Journal of Veterinary Diagnostic Investigation. 14(5). 407–411. 15 indexed citations
14.
Bowden, Raúl A., Silvia M. Estein, Michel S. Zygmunt, Gérard Dubray, & A. Cloeckaert. (2000). Identification of protective outer membrane antigens of by passive immunization of mice with monoclonal antibodies. Microbes and Infection. 2(5). 481–488. 48 indexed citations
15.
Bowden, Raúl A., et al.. (1999). Effect of Early Antibiotic Treatment on the Antibody Response to Cytoplasmic Proteins of Brucella melitensis in Mice. Clinical and Diagnostic Laboratory Immunology. 6(3). 440–443. 10 indexed citations
16.
Cloeckaert, Axel, et al.. (1997). Identification and characterization of Brucella ovis immunogenic proteins using two‐dimensional electrophoresis and immunoblotting. Electrophoresis. 18(8). 1491–1497. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026